Triple
T1172193
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Vumerity |
E24937
|
entity |
| Predicate | developedBy |
P73
|
FINISHED |
| Object |
Alkermes
Alkermes is a biopharmaceutical company that develops innovative medicines for central nervous system disorders and other serious chronic diseases.
|
E148148
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69a494082a7c819095004f423f294a64 |
elicitation | completed |
| NER | batch_69a4bceb3f188190b8b767380fe5986f |
ner | completed |
| NED1 | batch_69acacacf7c4819089708cf61b89903c |
ned_source_triple | completed |
| NED2 | batch_69acadba2e54819088a04675493fcbbb |
ned_description | completed |
| NEDg | batch_69acad4a7cd48190b295dbd1e5327a18 |
nedg | completed |
Created at: March 1, 2026, 7:45 p.m.